About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Since the first case of HIV/AIDS was reported in the early 1980’s, biopharmaceutical researchers and patient advocates have been focused on stopping the virus in its tracks and helping to enhance the health-related quality of life for people and communities affected by HIV.
Fast forward to the present, a diagnosis is now a manageable condition in which patients can expect to live a normal life expectancy with appropriate treatment thanks in part to the leadership of the biopharmaceutical industry.
When:
Thursday, November 30, 2023
Speakers:
- Andrew Powaleny, Senior Director of Public Affairs, PhRMA
- Dr. Jared Baeten, Senior Vice President, Clinical Development, Virology Therapeutic Area Head, Gilead Sciences
- Paul Schaper, Associate Vice President of Global Pharmaceutical Public Policy, Merck
- Dr. Kimberly Smith, Head of Research and Development at ViiV Healthcare, GSK’s HIV company
Watch the event here.